Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial

NCT01796678 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Vaso-occlusive Pain Episodes

Interventions

DRUG: Arginine
DRUG: Placebo

Sponsor

UCSF Benioff Children's Hospital Oakland